Stockscreener 앱 받기
0.2502
3.53%
0.00515
시간 외 거래:
.25
-0.0002
-0.08%
전일 마감가:
$0.245
열려 있는:
$0.2452
하루 거래량:
177.09K
Relative Volume:
0.16
시가총액:
$4.72M
수익:
$5.54M
순이익/손실:
$-4.74M
주가수익비율:
-0.7446
EPS:
-0.336
순현금흐름:
$-750.60K
1주 성능:
-3.83%
1개월 성능:
+20.87%
6개월 성능:
-1.28%
1년 성능:
-32.06%
1일 변동 폭
$0.2403
$0.2604
1주일 범위
$0.2368
$0.31
52주 변동 폭
$0.13
$0.41
China Pharma Holdings Inc. Stock (CPHI) Company Profile
명칭
China Pharma Holdings Inc.
전화
86 898 6681 1730
주소
No. 17, Jinpan Road, Second Floor, Haikou
CPHI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
0.2502 | 4.72M | 5.54M | -4.74M | -750.60K | -0.336 |
|
ZTS
Zoetis Inc
|
163.46 | 72.50B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.97 | 47.08B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.16 | 45.99B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.29 | 17.38B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
0.00 | 14.05B | 612.78M | -86.37M | -62.91M | -0.87 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2010-01-08 | 개시 | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. 주식(CPHI)의 최신 뉴스
China NT Pharma Reports Significant Losses for 2024 - TipRanks
Ascentage Pharma Reports Full Year 2024 Unaudited Financial Results and Business Updates - Yahoo Finance
Big pharma faces headwinds in China as vaccine sales decline - Yahoo
Ascentage Pharma to Present Five Preclinical Studies from Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2025 - Yahoo Finance
China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com - Defense World
Corbus Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Leadership Update - Quantisnow
Layoff Tracker: Vaxart Cuts 10% of Staff After US Government Orders Vaccine Trial Halt - BioSpace
Rhythm Pharmaceuticals Reacquires Licensing Rights to IMCIVREE® (setmelanotide) in China with Termination of Agreement with RareStone Ltd. - Yahoo Finance
Hedge funds, pharma CEOs on list of attendees for China business summit - Yahoo Finance
Prefilled Syringes Market Hits New High | Major Giants Weigao Group, YPSOMED AG , Boditech Med Inc - Newstrail
Is Amgen Inc. (AMGN) the Best Pharma Stock to Buy According to Hedge Funds? - Yahoo Finance
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Why AbbVie Inc. (ABBV) is the Best Pharma Stock to Buy According to Hedge Funds - Yahoo Finance
Is Bristol-Myers Squibb Company (BMY) the Best Pharma Stock to Buy According to Hedge Funds? - Yahoo Finance
Why Merck & Co., Inc. (MRK) is the Best Pharma Stock to Buy According to Hedge Funds - Yahoo Finance
Is Zoetis Inc. (ZTS) the Best Pharma Stock to Buy According to Hedge Funds? - Yahoo Finance
Is Eli Lilly and Company (LLY) the Best Pharma Stock to Buy According to Hedge Funds? - Yahoo Finance
SEC Form 10-K filed by Corbus Pharmaceuticals Holdings Inc. - Quantisnow
Is PDD Holdings Inc. (PDD) the Cheap Chinese Stock to Buy Now? - Insider Monkey
Aspen Pharmacare Holdings Ltd (APNHY) (H1 2025) Earnings Call Highlights: Strong Growth Amid ... - Yahoo Finance
Alliance Pharma And 2 Other UK Penny Stocks With Promising Fundamentals - Yahoo Finance
Harbour Biomed newco HBM Alpha pens $395M hyperplasia drug deal - BioWorld Online
Mayne Pharma Group Ltd (MAYNF) (H1 2025) Earnings Call Highlights: Strong Growth in Women's ... - Yahoo Finance
China Pharma (NYSE:CPHI) Now Covered by StockNews.com - Defense World
Can Euro Tech's $2.2M Water Treatment Deals Signal Growth in China's Environmental Tech Market? - StockTitan
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up – Here’s Why - Defense World
Hong Kong Pharma Digital Technology Holdings Limited Partners with Leading Chinese E-commerce Platform to Enhance Cross-Border Logistics Services - The Manila Times
Allspring Global Investments Holdings LLC Decreases Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - The AM Reporter
VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA - PR Newswire
InnoCare Pharma receives approval for CLL/SLL combination therapy trial in China - Yahoo
China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com - Defense World
Why AbbVie Inc. (ABBV) Is One of the Best Drug Stocks to Buy Now - Yahoo Finance
Is Pfizer Inc. (PFE) the Best Drug Stock to Buy Now? - Yahoo Finance
U.S. investors, Big Pharma race to find new medicines in China - MSN
Corbus Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits - Quantisnow
CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting ADC Demonstrates Encouraging Safety and Broader Efficacy in Phase 1 Study in the US and UK Presented at ASCO-GU 2025 - Quantisnow
Hong Kong Stock Exchange Companies List - Morningstar.com.au
China Pharma Holdings Inc (CPHI) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Post-Trade Analysis: China Pharma Holdings Inc (CPHI) Slides -7.63, Closing at 0.21 - The Dwinnex
Closing Bell Recap: International Paper Co (IP) Ends at 53.89, Reflecting a -3.47 Downturn - The Dwinnex
Big Pharma is staying quiet on Trump's China tariffs - Yahoo Finance
Wall Street Today: US stocks open flat amid China’s response to Trump tariffs; Nvidia up 3.19% - Mint
China Medical System Holdings Limited (HKG:867) insiders have significant skin in the game with 52% ownership - Simply Wall St
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Bought by China Universal Asset Management Co. Ltd. - MarketBeat
China Universal Asset Management Co. Ltd. Acquires 8,018 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Acquired by China Universal Asset Management Co. Ltd. - MarketBeat
China Pharma (NYSE:CPHI) Now Covered by Analysts at StockNews.com - Defense World
Pharmaceuticals Wholesale and Distribution Market to grow by USD 896.5 Billion (2024-2028), driven by rising global pharmaceutical sales, Report on how AI is redefining market landscapeTechnavio - Yahoo Finance
3 Leading Dividend Stocks Including Dawnrays Pharmaceutical Holdings - Simply Wall St
China NT Pharma Group to Hold Extraordinary General Meeting for New Share Subscription Approval - TipRanks
China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com - Defense World
China Pharma Holdings Inc. (CPHI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.37%
0.54%
자본화:
|
볼륨(24시간):